Transcriptional modulation of the NAD(P)H:quinone oxidoreductase 1 by mercury in human hepatoma HepG2 cells

Free Radical Biology and Medicine

Volumn 51, Issue 9, 2011, Pages 1675-1685

  Amara, Issa E A ^a   El Kadi, Ayman O S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aryl hydrocarbon receptor; Carcinogenesis; Free radicals; Mercury; NQO1

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; LUCIFERASE; MERCURY CHLORIDE; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BIOACCUMULATION; CARCINOGENESIS; CELL NUCLEUS; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION REGULATION;

BIOCATALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; ISOTHIOCYANATES; MERCURY; NAD(P)H DEHYDROGENASE (QUINONE); REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 80053588245     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.07.021     Document Type: Article

References (58)

1. P. Nioi, and J.D. Hayes Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors Mutat. Res. 555 2004 149 171 (Pubitemid 39359178)
2. P. Talalay, and A.T. Dinkova-Kostova Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates Methods Enzymol. 382 2004 355 364 (Pubitemid 38240799)
3. K. Iida, K. Itoh, Y. Kumagai, R. Oyasu, K. Hattori, K. Kawai, T. Shimazui, H. Akaza, and M. Yamamoto Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis Cancer Res. 64 2004 6424 6431 (Pubitemid 39297896)
4. X.L. Chen, and C. Kunsch Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases Curr. Pharm. Des. 10 2004 879 891 (Pubitemid 38380066)
5. W. Miao, L. Hu, P.J. Scrivens, and G. Batist Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes J. Biol. Chem. 280 2005 20340 20348 (Pubitemid 40776732)
6. H.J. Prochaska, and A.B. Santamaria Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers Anal. Biochem. 169 1988 328 336 (Pubitemid 18081406)
7. A. Anwar-Mohamed, and A.O. El-Kadi Down-regulation of the detoxifying enzyme NAD(P)H:quinone oxidoreductase 1 by vanadium in Hepa 1c1c7 cells Toxicol. Appl. Pharmacol. 236 2009 261 269
8. O. Hankinson The aryl hydrocarbon receptor complex Annu. Rev. Pharmacol. Toxicol. 35 1995 307 340
9. B.K. Meyer, M.G. Pray-Grant, J.P. Vanden Heuvel, and G.H. Perdew Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity Mol. Cell. Biol. 18 1998 978 988 (Pubitemid 28063432)
10. M.L. Whitelaw, J.A. Gustafsson, and L. Poellinger Identification of transactivation and repression functions of the dioxin receptor and its basic helix-loop-helix/PAS partner factor Arnt: inducible versus constitutive modes of regulation Mol. Cell. Biol. 14 1994 8343 8355 (Pubitemid 24373583)
11. H.J. Prochaska, and P. Talalay Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver Cancer Res. 48 1988 4776 4782
12. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322 (Pubitemid 27373291)
13. Q. Ma, K. Kinneer, Y. Bi, J.Y. Chan, and Y.W. Kan Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction Biochem. J. 377 2004 205 213 (Pubitemid 38114447)
14. H. Motohashi, and M. Yamamoto Nrf2-Keap1 defines a physiologically important stress response mechanism Trends Mol. Med. 10 2004 549 557 (Pubitemid 39433824)
15. X. Yu, and T. Kensler Nrf2 as a target for cancer chemoprevention Mutat. Res. 591 2005 93 102 (Pubitemid 41654841)
16. J.S. Lee, and Y.J. Surh Nrf2 as a novel molecular target for chemoprevention Cancer Lett. 224 2005 171 184
17. D. Ai, W. Pang, N. Li, M. Xu, P.D. Jones, J. Yang, Y. Zhang, N. Chiamvimonvat, J.Y. Shyy, B.D. Hammock, and Y. Zhu Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy Proc. Natl. Acad. Sci. U. S. A. 106 2009 564 569
18. Y. Zhang, P. Talalay, C.G. Cho, and G.H. Posner A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure Proc. Natl. Acad. Sci. U. S. A. 89 1992 2399 2403
19. Y. Zhang, T.W. Kensler, C.G. Cho, G.H. Posner, and P. Talalay Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates Proc. Natl. Acad. Sci. U. S. A. 91 1994 3147 3150 (Pubitemid 24130192)
20. E.J. Baran Vanadium detoxification: chemical and biochemical aspects Chem. Biodivers. 5 2008 1475 1484
21. Canadian Environmental Protection Act Registry 2006
22. Agency for Toxic Substances and Diseases Registry 2005
23. I.E. Amara, A. Anwar-Mohamed, and A.O. El-Kadi Mercury modulates the CYP1A1 at transcriptional and posttranslational levels in human hepatoma HepG2 cells Toxicol. Lett. 199 2010 225 233
24. S.A. Rushworth, D.J. MacEwan, and M.A. O'Connell Lipopolysaccharide- induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes J. Immunol. 181 2008 6730 6737
25. W.M. Westerink, and W.G. Schoonen Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells Toxicol. In Vitro 21 2007 1592 1602 (Pubitemid 350103539)
26. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(- ΔΔC(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
27. O. Aparicio, J. V. G., E. Sekinger, A. Yang, Z. Moqtaderi, and K. Struhl Chromatin immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo Curr. Protoc. Mol. Biol. 69 2005 21.3.16 21.3.17 (21.23.16-21.23.17)
28. N.C. Andrews, and D.V. Faller A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells Nucleic Acids Res. 19 1991 2499
29. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
30. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
31. L. Ernster DT diaphorase Methods Enzymol. 10 1967 309 317
32. R.H. Elbekai, and A.O. El-Kadi Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium Toxicol. Lett. 172 2007 106 119 (Pubitemid 47187594)
33. A. Anwar-Mohamed, and A.O. El-Kadi Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium Drug Metab. Dispos. 36 2008 1819 1827
34. R. Venugopal, and A.K. Jaiswal Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene Proc. Natl. Acad. Sci. U. S. A. 93 1996 14960 14965 (Pubitemid 26419078)
35. D.J. Long II, R.L. Waikel, X.J. Wang, L. Perlaky, D.R. Roop, and A.K. Jaiswal NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis Cancer Res. 60 2000 5913 5915
36. D.D. Vakharia, N. Liu, R. Pause, M. Fasco, E. Bessette, Q.Y. Zhang, and L.S. Kaminsky Polycyclic aromatic hydrocarbon/metal mixtures: effect on PAH induction of CYP1A1 in human HEPG2 cells Drug Metab. Dispos. 29 2001 999 1006 (Pubitemid 32605915)
37. H.M. Korashy, and A.O. El-Kadi Modulation of TCDD-mediated induction of cytochrome P450 1A1 by mercury, lead, and copper in human HepG2 cell line Toxicol. In Vitro 22 2008 154 158 (Pubitemid 350267107)
38. H. Kikuchi, H. Kato, M. Mizuno, A. Hossain, S. Ikawa, J. Miyazaki, and M. Watanabe Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction Arch. Biochem. Biophys. 334 1996 235 240 (Pubitemid 26347305)
39. W.K. Kim, Y.J. In, J.H. Kim, H.J. Cho, J.H. Kim, S. Kang, C.Y. Lee, and S.C. Lee Quantitative relationship of dioxin-responsive gene expression to dioxin response element in Hep3B and HepG2 human hepatocarcinoma cell lines Toxicol. Lett. 165 2006 174 181
40. S. Krusekopf, U. Kleeberg, A.G. Hildebrandt, and K. Ruckpaul Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line Xenobiotica 27 1997 1 9 (Pubitemid 27068368)
41. H.P. Lipp, D. Schrenk, T. Wiesmuller, H. Hagenmaier, and K.W. Bock Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and their constituents in human HepG2 cells Arch. Toxicol. 66 1992 220 223
42. Z.Q. Jiang, C. Chen, B. Yang, V. Hebbar, and A.N. Kong Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers Life Sci. 72 2003 2243 2253 (Pubitemid 36287361)
43. A.S. Keck, R. Staack, and E.H. Jeffery The cruciferous nitrile crambene has bioactivity similar to sulforaphane when administered to Fischer 344 rats but is far less potent in cell culture Nutr. Cancer 42 2002 233 240 (Pubitemid 35253674)
44. D.A. Bloom, and A.K. Jaiswal Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression J. Biol. Chem. 278 2003 44675 44682 (Pubitemid 37377224)
45. N. Ercal, H. Gurer-Orhan, and N. Aykin-Burns Toxic metals and oxidative stress. Part I. Mechanisms involved in metal-induced oxidative damage Curr. Top. Med. Chem. 1 2001 529 539
46. A. Anwar-Mohamed, R.H. Elbekai, and A.O. El-Kadi Regulation of CYP1A1 by heavy metals and consequences for drug metabolism Expert Opin. Drug Metab. Toxicol. 5 2009 501 521
47. H.M. Korashy, and A.O. El-Kadi Transcriptional regulation of the NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase ya genes by mercury, lead, and copper Drug Metab. Dispos. 34 2006 152 165 (Pubitemid 43042657)
48. H.M. Korashy, and A.O. El-Kadi Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells Toxicology 201 2004 153 172 (Pubitemid 39023943)
49. J.C. Wataha, J.B. Lewis, V.V. McCloud, M. Shaw, Y. Omata, P.E. Lockwood, R.L. Messer, and J.M. Hansen Effect of mercury(II) on Nrf2, thioredoxin reductase-1 and thioredoxin-1 in human monocytes Dent. Mater. 24 2008 765 772 (Pubitemid 351626159)
50. P. Nioi, M. McMahon, K. Itoh, M. Yamamoto, and J.D. Hayes Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence Biochem. J. 374 2003 337 348 (Pubitemid 37094093)
51. H.M. Korashy, and A.O. El-Kadi NF-kappaB and AP-1 are key signaling pathways in the modulation of NAD(P)H:quinone oxidoreductase 1 gene by mercury, lead, and copper J. Biochem. Mol. Toxicol. 22 2008 274 283
52. T.H. Rushmore, and A.N. Kong Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes Curr. Drug Metab. 3 2002 481 490 (Pubitemid 34987481)
53. C. Xu, C.Y. Li, and A.N. Kong Induction of phase I, II and III drug metabolism/transport by xenobiotics Arch. Pharm. Res. 28 2005 249 268 (Pubitemid 44698742)
54. A.K. Jaiswal Nrf2 signaling in coordinated activation of antioxidant gene expression Free Radic. Biol. Med. 36 2004 1199 1207 (Pubitemid 38526313)
55. A. Anwar-Mohamed, O.S. Degenhardt, M.A. El Gendy, J.M. Seubert, S.R. Kleeberger, and A.O. El-Kadi The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers Toxicol. In Vitro 25 2011 785 795
56. S. Shin, N. Wakabayashi, V. Misra, S. Biswal, G.H. Lee, E.S. Agoston, M. Yamamoto, and T.W. Kensler NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis Mol. Cell. Biol. 27 2007 7188 7197 (Pubitemid 47549754)
57. R.L. Yeager, S.A. Reisman, L.M. Aleksunes, and C.D. Klaassen Introducing the "TCDD-inducible AhR-Nrf2 gene battery" Toxicol. Sci. 111 2009 238 246
58. T. Toyama, Y. Shinkai, A. Yasutake, K. Uchida, M. Yamamoto, and Y. Kumagai Isothiocyanates reduce mercury accumulation via an Nrf2-dependent mechanism during exposure of mice to methylmercury Environ. Health Perspect. 119 2011 1117 1122